We are live on ! Find out more
RCM

Riverhead Capital Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 2.34%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+2.34%
3 Year Est. Return
+45.7%
5 Year Est. Return
+71.11%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$154M
Cap. Flow
+$127M
Cap. Flow %
5%
Top 10 Hldgs %
10.97%
Holding
1,606
New
64
Increased
621
Reduced
247
Closed
65

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.22M
2
SLG icon
SL Green Realty
SLG
+$6.1M
3
CI icon
Cigna
CI
+$5.43M
4
CTSH icon
Cognizant
CTSH
+$5.34M
5
PHM icon
Pultegroup
PHM
+$5M

Top Sells

Rank Stock Value
1
TNL icon
Travel + Leisure Co
TNL
+$8.52M
2
ELV icon
Elevance Health
ELV
+$7.94M
3
LNC icon
Lincoln National
LNC
+$7.53M
4
ISRG icon
Intuitive Surgical
ISRG
+$6.48M
5
HPQ icon
HP
HPQ
+$5.78M

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Financials 14.65%
3 Consumer Discretionary 12.9%
4 Healthcare 12.36%
5 Industrials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JHX icon
1501
James Hardie Industries
JHX
$15.3B
$27K ﹤0.01%
1,600
– –
EVHC
1502
DELISTED
Envision Healthcare Holdings Inc
EVHC
$26K ﹤0.01%
589
-11,289
-95% -$464K
B
1503
Barrick Mining
B
$61.5B
$25K ﹤0.01%
1,900
– –
KURA icon
1504
Kura Oncology
KURA
$800M
$24K ﹤0.01%
1,318
+1,053
+397% +$17.8K
FSB
1505
DELISTED
Franklin Financial Network, Inc.
FSB
$23K ﹤0.01%
+600
New +$21.2K
ZGNX
1506
DELISTED
Zogenix, Inc.
ZGNX
$23K ﹤0.01%
+520
New +$21.4K
CYTK icon
1507
Cytokinetics
CYTK
$10.5B
$22K ﹤0.01%
+2,600
New +$21.6K
GKOS icon
1508
Glaukos
GKOS
$9.83B
$22K ﹤0.01%
+547
New +$19.5K
SCG
1509
DELISTED
Scana
SCG
$22K ﹤0.01%
+564
New +$20.5K
CCJ icon
1510
Cameco
CCJ
$37.6B
$21K ﹤0.01%
1,900
– –
OVV icon
1511
Ovintiv
OVV
$17.3B
$21K ﹤0.01%
320
– –
CRR
1512
DELISTED
Carbo Ceramics Inc.
CRR
$20K ﹤0.01%
+2,200
New +$19.7K
LBTYA icon
1513
Liberty Global Class A
LBTYA
$3.62B
$17K ﹤0.01%
600
– –
TRQ
1514
DELISTED
Turquoise Hill Resources Ltd
TRQ
$17K ﹤0.01%
590
– –
LBTYK icon
1515
Liberty Global Class C
LBTYK
$3.53B
$16K ﹤0.01%
600
– –
SNDX icon
1516
Syndax Pharmaceuticals
SNDX
$1.69B
$15K ﹤0.01%
+2,199
New +$21.6K
ALDR
1517
DELISTED
Alder Biopharmaceuticals
ALDR
$15K ﹤0.01%
+965
New +$14.7K
CSTE icon
1518
Caesarstone
CSTE
$72.3M
$14K ﹤0.01%
900
– –
AGIO icon
1519
Agios Pharmaceuticals
AGIO
$1.79B
$13K ﹤0.01%
149
+77
+107% +$6.71K
HEI.A icon
1520
HEICO Corp Class A
HEI.A
$36B
$13K ﹤0.01%
+213
New +$12.7K
TBHC
1521
DELISTED
The Brand House Collective
TBHC
$13K ﹤0.01%
+1,100
New +$12.3K
BBU
1522
DELISTED
Brookfield Business Partners
BBU
$11K ﹤0.01%
467
– –
KALA icon
1523
KALA BIO
KALA
$14.1M
– –
0
– –
VRN
1524
DELISTED
Veren
VRN
$11K ﹤0.01%
1,500
– –
GTHX
1525
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$11K ﹤0.01%
249
+58
+30% +$2.48K
59 60
61
62 63

Similar funds

TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Riverhead Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Riverhead Capital Management held 1,606 positions worth $2.53B, up 6.5% from $2.38B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Riverhead Capital Management deployed $127M of net new capital in Q2 2018, opening 64 new positions and adding to 621 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 22,879 shares worth $6.25M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Travel + Leisure Co, an estimated $8.52M trimmed.

  • Riverhead Capital Management's largest Q2 2018 buy was iShares Core S&P 500 ETF: 22,879 shares worth $6.25M.
  • Riverhead Capital Management added most to SL Green Realty in Q2 2018, an estimated $6.1M increase.
  • Riverhead Capital Management's biggest Q2 2018 reduction was Travel + Leisure Co, cutting an estimated $8.52M.
  • Riverhead Capital Management fully exited Take-Two Interactive in Q2 2018, selling an estimated $3.12M.
  • Riverhead Capital Management's ten largest holdings make up 11% of its $2.53B portfolio in Q2 2018.
  • Riverhead Capital Management opened 64 new positions and closed 65 in Q2 2018.
  • Riverhead Capital Management's portfolio value rose 6.5% quarter-over-quarter to $2.53B.

Based on Riverhead Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.